Swiss Re Insurance-Linked Fund Management

PCS - Emerging Risks, New Opportunities

longevity

Share

Karson Management completes $825 million Regulation XXX transaction for ING Insurance

13th January 2010

A very interesting press release arrived in my email inbox this evening announcing and innovative transaction in the Regulation XXX arena that has just been completed. Karson Management, a company formed by well known industry experts has set up a specialist alternative collateral provider to provide collateral to insurance and reinsurance companies, Lloyd’s members and […]

Read the full article

Centurion launches first ever macro/micro longevity fund

3rd January 2010

In a first for longevity risk Centurion Fund Managers have launched a new fund which is the first in the market to include macro and micro longevity. By combining these two aspects the fund allows investors to better diversify their portfolios of life insurance linked securitization and products.

Read the full article

Market for longevity risk set to grow

14th December 2009

The market for trading and securitization of longevity risks has never really taken off as much as we initially thought it would. Most market participants have been waiting for capital to flood in as companies and pension fund managers discovered how easily they could hedge the risk of longevity amongst the members of pension schemes. […]

Read the full article

Swiss Re completes new Vita Capital IV Ltd. mortality bond

24th November 2009

Swiss Re have now completed their latest life insurance securitization, Vita Capital IV Ltd. The mortality bond transaction provides Swiss Re with $75m of cover against severe population mortality in the U.S. or the UK. The deal covers a five-year risk period ending in 2014. The notes issued by Vita Capital have been rated ‘BB+’ […]

Read the full article

Swiss Re preparing Vita Capital IV mortality bond

18th November 2009

Various sources are reporting that Swiss Re is preparing to launch a fourth excess mortality transaction under its Vita series. Vita Capital IV is said to be a $75m mortality bond, it started as $50m but demand has been high and the deal has upsized significantly. It’s assumed that Vita Capital IV will replace a […]

Read the full article

Moody’s withdraws ratings of Genworth life insurance-linked securities

11th November 2009

We last reported on Genworth and its River Lake transactions back in July at which time River Lake transactions were being reviewed for credit worthiness. Now Moody’s reports that it has withdrawn all ratings on certain Genworth sponsored and MBIA Insurance Corporation backed life insurance-linked securitizations. River Lake I, II, IV and Rivermont are all […]

Read the full article

Pension Corp. urges British government to issue longevity bonds

26th October 2009

Here’s some interesting reading for a Monday morning. Pension Corporation has joined the Pension Institute (who asked this question previously) in urging the British government to issue longevity linked bonds to help pension schemes and insurers manage the risks associated with increasing life expectancy of the British population. The fact that the population are living […]

Read the full article

Axis Capital expecting $136m loss from longevity risk derivative

16th October 2009

Axis Capital, the Bermudian reinsurer, has announced in its preliminary third-quarter results that it expects to lose around $136m due to a longevity risk derivative contract. The final loss will be unveiled in the reinsurers official third-quarter results filing. The derivative contract doesn’t expire until 2017 but Axis will have to carry those losses on […]

Read the full article

Norwich Union transfers longevity risks to the capital markets

23rd March 2009

UK insurer Norwich Union has entered into a deal with Royal Bank of Scotland and Partner Re to transfer £475m of longevity related risks to the capital markets through what is essentially a longevity swap. The transaction will provide cover for these annuity/pension related risks up to 2018. Transferring these longevity risks to the capital […]

Read the full article